Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Pharmaceutical Research|March 27, 2007
Novel liposomal formulation for targeted gene deliveryVéronique Rivest, Alix Phivilay, Carl Julien, et al.Methods in Molecular Biology (Clifton, N.J.)|March 21, 2024
Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of TauopathiesGeoffrey Canet, Emma Rocaboy, Sofia Diego-Diàz, et al.Journal of Neuroscience Research|March 15, 2008
Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathologyCarl Julien, Cyntia Tremblay, Farid Bendjelloul, et al.Journal of Neuropathology and Experimental Neurology|December 24, 2008
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer diseaseCarl Julien, Cyntia Tremblay, Vincent Emond, et al.The European Journal of Neuroscience|August 24, 2010
Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's diseaseLaura K Hamilton, Anne Aumont, Carl Julien, et al.Journal of Alzheimer'S Disease : JAD|September 15, 2011
Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's diseaseMeryem Lebbadi, Carl Julien, Alix Phivilay, et al.Stroke|August 20, 2011
Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damageMélanie Lalancette-Hébert, Carl Julien, Pierre Cordeau, et al.Plos One|July 7, 2012
Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylationCarl Julien, François Marcouiller, Alexis Bretteville, et al.Neuropharmacology|August 26, 2009
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's diseaseFanchon Bourasset, Mélissa Ouellet, Cyntia Tremblay, et al.Acta Neuropathologica Communications|December 1, 2018
In vivo induction of membrane damage by β-amyloid peptide oligomersCarl Julien, Colson Tomberlin, Christine M Roberts, et al.Pageof 4